Charles River Laboratories International, Inc. (CRL)
USD 183.16
(-3.26%)
USD 183.16
(-3.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 380.25 Million USD | 48.65% |
| 2022 | 255.8 Million USD | 28.45% |
| 2021 | 199.14 Million USD | 7.24% |
| 2020 | 185.69 Million USD | 15.58% |
| 2019 | 160.66 Million USD | 25.62% |
| 2018 | 127.89 Million USD | 11.25% |
| 2017 | 114.95 Million USD | 19.95% |
| 2016 | 95.83 Million USD | 2.24% |
| 2015 | 93.73 Million USD | 5.27% |
| 2014 | 89.04 Million USD | -0.39% |
| 2013 | 89.39 Million USD | 1.05% |
| 2012 | 88.47 Million USD | -4.84% |
| 2011 | 92.96 Million USD | -7.31% |
| 2010 | 100.29 Million USD | -2.36% |
| 2009 | 102.72 Million USD | 6.03% |
| 2008 | 96.88 Million USD | 10.06% |
| 2007 | 88.02 Million USD | 21.64% |
| 2006 | 72.36 Million USD | 10.87% |
| 2005 | 65.27 Million USD | 5.42% |
| 2004 | 61.91 Million USD | 18.22% |
| 2003 | 52.37 Million USD | 19.32% |
| 2002 | 43.89 Million USD | 12.38% |
| 2001 | 39.05 Million USD | 15.24% |
| 2000 | 33.89 Million USD | 10.99% |
| 1999 | 30.53 Million USD | -0.64% |
| 1998 | 30.73 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 361.28 Million USD | -4.99% |
| 2024 Q2 | 349.11 Million USD | -3.37% |
| 2023 Q2 | 285.28 Million USD | 8.64% |
| 2023 FY | 380.25 Million USD | 48.65% |
| 2023 Q3 | 292.97 Million USD | 2.7% |
| 2023 Q1 | 262.58 Million USD | 2.65% |
| 2023 Q4 | 380.25 Million USD | 29.79% |
| 2022 Q3 | 261.52 Million USD | 1.85% |
| 2022 Q1 | 221.17 Million USD | 11.06% |
| 2022 FY | 255.8 Million USD | 28.45% |
| 2022 Q4 | 255.8 Million USD | -2.18% |
| 2022 Q2 | 256.76 Million USD | 16.09% |
| 2021 Q2 | 194.34 Million USD | 0.39% |
| 2021 Q4 | 199.14 Million USD | 9.61% |
| 2021 FY | 199.14 Million USD | 7.24% |
| 2021 Q1 | 193.58 Million USD | 4.25% |
| 2021 Q3 | 181.69 Million USD | -6.51% |
| 2020 Q4 | 185.69 Million USD | 2.39% |
| 2020 Q1 | 162.93 Million USD | 1.42% |
| 2020 Q3 | 181.36 Million USD | 7.72% |
| 2020 Q2 | 168.36 Million USD | 3.33% |
| 2020 FY | 185.69 Million USD | 15.58% |
| 2019 Q3 | 155.52 Million USD | 15.27% |
| 2019 Q2 | 134.92 Million USD | 3.98% |
| 2019 FY | 160.66 Million USD | 25.62% |
| 2019 Q4 | 160.66 Million USD | 3.3% |
| 2019 Q1 | 129.76 Million USD | 1.46% |
| 2018 Q1 | 119.04 Million USD | 3.56% |
| 2018 Q3 | 125.5 Million USD | 1.1% |
| 2018 Q4 | 127.89 Million USD | 1.91% |
| 2018 FY | 127.89 Million USD | 11.25% |
| 2018 Q2 | 124.13 Million USD | 4.27% |
| 2017 Q2 | 104.69 Million USD | 6.3% |
| 2017 Q4 | 114.95 Million USD | 7.06% |
| 2017 FY | 114.95 Million USD | 19.95% |
| 2017 Q1 | 98.48 Million USD | 2.76% |
| 2017 Q3 | 107.37 Million USD | 2.56% |
| 2016 Q2 | 98.11 Million USD | 1.05% |
| 2016 FY | 95.83 Million USD | 2.24% |
| 2016 Q3 | 99.37 Million USD | 1.28% |
| 2016 Q4 | 95.83 Million USD | -3.56% |
| 2016 Q1 | 97.1 Million USD | 3.59% |
| 2015 Q1 | 86.05 Million USD | -3.36% |
| 2015 FY | 93.73 Million USD | 5.27% |
| 2015 Q4 | 93.73 Million USD | -4.45% |
| 2015 Q3 | 98.09 Million USD | 8.95% |
| 2015 Q2 | 90.03 Million USD | 4.63% |
| 2014 Q1 | 91.67 Million USD | 2.55% |
| 2014 Q2 | 92.62 Million USD | 1.03% |
| 2014 FY | 89.04 Million USD | -0.39% |
| 2014 Q4 | 89.04 Million USD | -3.94% |
| 2014 Q3 | 92.69 Million USD | 0.08% |
| 2013 FY | 89.39 Million USD | 1.05% |
| 2013 Q3 | 87.14 Million USD | -1.42% |
| 2013 Q1 | 84.95 Million USD | -3.97% |
| 2013 Q2 | 88.4 Million USD | 4.06% |
| 2013 Q4 | 89.39 Million USD | 2.58% |
| 2012 Q2 | 92.28 Million USD | 3.29% |
| 2012 FY | 88.47 Million USD | -4.84% |
| 2012 Q1 | 89.34 Million USD | -3.9% |
| 2012 Q4 | 88.47 Million USD | -5.6% |
| 2012 Q3 | 93.71 Million USD | 1.55% |
| 2011 Q2 | 100.53 Million USD | 3.01% |
| 2011 Q4 | 92.96 Million USD | -1.51% |
| 2011 FY | 92.96 Million USD | -7.31% |
| 2011 Q1 | 97.59 Million USD | -2.69% |
| 2011 Q3 | 94.39 Million USD | -6.11% |
| 2010 Q2 | 96.57 Million USD | -1.03% |
| 2010 Q1 | 97.57 Million USD | -5.01% |
| 2010 FY | 100.29 Million USD | -2.36% |
| 2010 Q4 | 100.29 Million USD | -0.46% |
| 2010 Q3 | 100.75 Million USD | 4.34% |
| 2009 Q1 | 97.56 Million USD | 0.7% |
| 2009 FY | 102.72 Million USD | 6.03% |
| 2009 Q4 | 102.72 Million USD | 2.43% |
| 2009 Q3 | 100.29 Million USD | 4.03% |
| 2009 Q2 | 96.4 Million USD | -1.19% |
| 2008 Q3 | 93.53 Million USD | -0.07% |
| 2008 Q1 | 90.88 Million USD | 3.25% |
| 2008 FY | 96.88 Million USD | 10.06% |
| 2008 Q4 | 96.88 Million USD | 3.58% |
| 2008 Q2 | 93.6 Million USD | 2.99% |
| 2007 Q4 | 88.02 Million USD | 9.71% |
| 2007 Q1 | 75.68 Million USD | 4.59% |
| 2007 FY | 88.02 Million USD | 21.64% |
| 2007 Q3 | 80.23 Million USD | 3.97% |
| 2007 Q2 | 77.16 Million USD | 1.97% |
| 2006 Q1 | 68.16 Million USD | 4.44% |
| 2006 FY | 72.36 Million USD | 10.87% |
| 2006 Q4 | 72.36 Million USD | 0.75% |
| 2006 Q3 | 71.82 Million USD | 4.03% |
| 2006 Q2 | 69.03 Million USD | 1.27% |
| 2005 FY | 65.27 Million USD | 5.42% |
| 2005 Q4 | 65.27 Million USD | 0.38% |
| 2005 Q3 | 65.02 Million USD | 7.7% |
| 2005 Q2 | 60.37 Million USD | -5.19% |
| 2005 Q1 | 63.68 Million USD | 2.85% |
| 2004 FY | 61.91 Million USD | 18.22% |
| 2004 Q4 | 61.91 Million USD | 11.41% |
| 2004 Q3 | 55.57 Million USD | 1.64% |
| 2004 Q2 | 54.67 Million USD | 3.07% |
| 2004 Q1 | 53.05 Million USD | 1.3% |
| 2003 Q3 | 48.54 Million USD | 3.62% |
| 2003 Q4 | 52.37 Million USD | 7.89% |
| 2003 FY | 52.37 Million USD | 19.32% |
| 2003 Q2 | 46.84 Million USD | 2.81% |
| 2003 Q1 | 45.56 Million USD | 3.81% |
| 2002 Q1 | 39.12 Million USD | 0.18% |
| 2002 FY | 43.89 Million USD | 12.38% |
| 2002 Q4 | 43.89 Million USD | 4.7% |
| 2002 Q3 | 41.92 Million USD | 6.25% |
| 2002 Q2 | 39.45 Million USD | 0.84% |
| 2001 Q1 | 34.28 Million USD | 1.17% |
| 2001 Q2 | 36.6 Million USD | 6.77% |
| 2001 FY | 39.05 Million USD | 15.24% |
| 2001 Q3 | 39.2 Million USD | 7.1% |
| 2001 Q4 | 39.05 Million USD | -0.38% |
| 2000 Q3 | 31.54 Million USD | -2.01% |
| 2000 Q1 | 32.46 Million USD | 0.0% |
| 2000 Q2 | 32.19 Million USD | -0.83% |
| 2000 Q4 | 33.89 Million USD | 7.44% |
| 2000 FY | 33.89 Million USD | 10.99% |
| 1999 FY | 30.53 Million USD | -0.64% |
| 1998 FY | 30.73 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.03 Billion USD | 63.117% |
| Quest Diagnostics Incorporated | 190 Million USD | -100.136% |
| Danaher Corporation | 2.59 Billion USD | 85.341% |
| Enzo Biochem, Inc. | 6.83 Million USD | -5465.852% |
| IQVIA Holdings Inc. | - USD | -Infinity% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | 19.878% |
| Mettler-Toledo International Inc. | 385.86 Million USD | 1.453% |
| Qiagen N.V. | 398.38 Million USD | 4.55% |
| Revvity, Inc. | 428.06 Million USD | 11.167% |
| Thermo Fisher Scientific Inc. | 5.08 Billion USD | 92.526% |
| Waters Corporation | 516.23 Million USD | 26.34% |